The application discloses compounds of Formula I: ##STR00001## wherein Q.sup.1, Q.sup.2, R.sup.1, R.sup.2, R.sup.3, and n are defined as described herein. Also provided are pharmaceutical compositions, methods of using, and methods of preparing the subject compounds.

 
Web www.patentalert.com

< FATTY ACID ACETYLATED SALICYLATES AND THEIR USES

> Therapeutic agent for diabetes

> ANTIOXIDANT INFLAMMATION MODULATORS: C-17 HOMOLOGATED OLEANOLIC ACID DERIVATIVES

~ 00579